New Agents and New Applications of Targeted Therapy For Hormone Receptor Positive Breast Cancer
Alberto Montero, MD, MBA, CPHQ
Novel Advances in Radiation Oncology Beyond SRS and Proton Therapy: What Is Next?
Puneeth Iyengar, MD, PhD
Novel Platforms to Assess the Cancer Continuom Using Liquid Biopsy
Christian Rolfo, MD, PhD, MBA, Dr.h.c.
Cost of Medications: How to Make Them Affordable—Are We on the Right Direction?
Dina Dumercy McHenry, PharmD, MBA, BCOP, CSSGB
Management of EGFR Mutant NSCLC Patients and Future Directions (excluding Resistance to EGFR TKIs)
Roy S. Herbst, MD, PhD, FACP, FASCO
